SCHEMBL9489016

SCHEMBL9489016

COC(=O)N(CC(=O)O)C(=O)c1c(F)ccc2c(C(F)(F)F)c(OC)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 1/20 0.50
AKR1A1 P14550 1/20 0.50
AKR1B1 P15121 1/20 0.50
PTGDR2 Q9Y5Y4 3/20 0.33
TBXA2R P21731 2/20 0.33
PTGDR Q13258 2/20 0.33
GAA P10253 1/20 0.33
FABP4 P15090 1/20 0.32
PPARA Q07869 3/20 0.32
PPARG P37231 2/20 0.32
GYS1 P13807 1/20 0.32
CETP P11597 2/20 0.32
KCNN4 O15554 1/20 0.32
CYP2C9 P11712 1/20 0.32
PPARD Q03181 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
PDE4A P27815 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9489202 0.90 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9490893 0.90 AKR1B10 (0.42) AKR1B10AKR1A1AKR1B1GAACETP
SCHEMBL9489025 0.89 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9489492 0.89 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9491827 0.88 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9489702 0.85 AKR1B10 (0.61) AKR1B10AKR1A1AKR1B1GAAGYS1
SCHEMBL10416197 0.83 AKR1B10 (0.66) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9489172 0.80 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1PTGDR2TBXA2R
SCHEMBL9490667 0.80 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1GAALMNA
SCHEMBL9491073 0.79 AKR1B10 (0.46) AKR1B10AKR1A1AKR1B1CYP2C9RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP claimed
WO-1989005793-A1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-29 WO claimed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP claimed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US claimed
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP disclosed
WO-1989005793-A1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-29 WO disclosed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP disclosed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US disclosed